1. Home
  2. CCEL vs KNRX Comparison

CCEL vs KNRX Comparison

Compare CCEL & KNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

HOLD

Current Price

$3.75

Market Cap

27.8M

Sector

Health Care

ML Signal

HOLD

KNRX

KNOREX LTD. Class A Ordinary Shares

N/A

Current Price

$0.78

Market Cap

30.3M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CCEL
KNRX
Founded
1989
2009
Country
United States
Singapore
Employees
N/A
N/A
Industry
Managed Health Care
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
27.8M
30.3M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
CCEL
KNRX
Price
$3.75
$0.78
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
7.8K
278.6K
Earning Date
04-14-2026
06-12-2026
Dividend Yield
4.26%
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$25,384,279.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$368.00
N/A
Revenue Growth
9.76
N/A
52 Week Low
$2.72
$0.76
52 Week High
$5.52
$3.45

Technical Indicators

Market Signals
Indicator
CCEL
KNRX
Relative Strength Index (RSI) 52.34 28.95
Support Level $3.18 N/A
Resistance Level $4.08 $1.46
Average True Range (ATR) 0.24 0.13
MACD -0.01 -0.03
Stochastic Oscillator 30.43 2.18

Price Performance

Historical Comparison
CCEL
KNRX

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About KNRX KNOREX LTD. Class A Ordinary Shares

Knorex Ltd is a B2B technology company providing programmatic advertising products and solutions to marketers to streamline and automate their advertising and marketing workflows. Its software offers marketers cost-effective solutions and productivity-enhancing capabilities to target audience across various advertising channels and devices through automated processes and algorithms, which is known as programmatic advertising. Its product, Knorex XPOSM, is a self-service enterprise-grade cloud platform with a suite of advertising management and execution (AMX) applications. The Company operates in one operating segment, which focuses on platform subscription fee, platform services, managed activations, and professional services.

Share on Social Networks: